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A series of new core-shell fibers were developed containing anticancer drugs (5-fluorouracil
or ferulic acid) and their cyclodextrin inclusion complexes, with a gadolinium-based magnetic
resonance imaging (MRI) contrast agent. These were prepared by electrospinning, a simple method
for producing ultra-fine fibers through the application of a strong electrostatic force on a polymer
solution. The shell of the fibers was formed from Eudragit S100, and the drugs were loaded in the
core. Scanning electron microscopy images showed the formation of smooth ribbon-like fibers, with
diameters ranging from 1.4 to 5.1 µm, and transmission electron microscopy reveals a transparent
interface between the core and shell compartments. X-ray diffraction and differential scanning
calorimetry data confirmed the encapsulation of the drug into the cyclodextrin cavity and the
formation of amorphous solid dispersions in the fibers. Drug release from the systems at pH 1 and 7
showed that all the drug loading was released within one hour at pH 1. Based on these results, it is
proposed that the relatively low molecular weight drugs were able to diffuse out of the system into
the release medium at acidic pH, despite the insolubility of the shell polymer under these conditions.
These findings have important implications for the design of electrospun drug delivery systems.
Keywords: Electrospinning, Polymer fibers, Anticancer, Cyclodextrin, Inclusion Complex, Eudragit
S100

INTRODUCTION
Electrospinning is a straightforward process for
producing ultra-fine fibers with diameters typically on the
nanometer to micrometer scale through the application
of a strong electrostatic force on a polymer solution or
melt (Hu et al., 2014). It is a widespread technique for
the fabrication of nanofibers because of its simplicity,
versatility, cost-effectiveness, the possibility for scaleup, and the ability to use a broad range of polymers
(Zamani et al., 2013). High drug loadings and controlled
drug release profiles at the site of interest can be elicited
(Hu et al., 2014).
Electrospinning involves the application of a high
electric potential (kV) to the tip of a spinneret through
which a polymer solution is fed. When the potential
reaches a critical voltage, the polymer droplet at the
end of the syringe will deform into a conical shape (the
Taylor cone) and emit a jet, which later is deposited
on a grounded collector. Ideally, before reaching the
collector, the solvent is fully evaporated (Gunn & Zhang,
2010). Further development of the electrospinning
approach has allowed the formation of fibers with a
core-shell structure by the coaxial method, a technique
that uses two concentric needles with different diameters
to simultaneously dispense two various fluids. This
E-ISSN 2477-0612

technique allows multiple drugs and/or diagnostic agents
to be loaded into a single nanofiber with precise control
of spatial location (Son et al. 2014; Zhang et al., 2016).
For instance, the shell can act as a barrier to slow the
release of a core-loaded drug. Localized drug delivery
can also be achieved, which can allow a decrease in the
required dose and provide more effective therapy with
reduced side effects.
Here, we use two model drugs. The first, 5-fluorouracil
(5FU), is an antimetabolism pyrimidine that inhibits
cancer cell growth. It is a very low molecular weight
drug, and its aqueous solubility is relatively high at low
pH. Although it has been widely used in the treatment
of breast, colorectal, gastrointestinal and ovarian cancer,
5FU has a short-biological half-life and usually is
given in high doses, which induces systemic toxicity
(Illangakoon et al., 2015; Wang et al., 2016). The second,
ferulic acid (FA), is a hydrophobic phenolic compound
found in many plant tissues and which has a potential
anticancer effect due to its antioxidant activity, allowing
it to scavenge free radicals and regulate cell growth and
proliferation (Ghosh et al., 2017). An antiproliferative
effect of FA has been reported in various cancer cell
lines (Mancuso & Santangelo, 2014; Roy et al., 2016;
Vashisth et al., 2015).
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Systemic administration of anticancer agents can be
problematic owing to the fact that they typically have poor
solubility and/or stability in the biological environment;
often there is a low local concentration at the tumor site,
which leads to reduced efficacy and severe side effects on
healthy tissues (Zamani et al., 2013). These effects can
be reduced by preparing systems which deliver the drug
specifically to the site of action. One route to achieve
this is through the generation of electrospun fibers. For
instance, indomethacin and sodium diclofenac were
successfully fabricated into nanofibers for colonic drug
delivery (Akhgari et al., 2017; Shen et al., 2011). Studies
to target 5-fluorouracil and ferulic acid (FA) delivery to
the colon by electrospinning have also been reported
(Illangakoon et al., 2015; Shen et al., 2011). Research
conducted by Wang et al. (2015) prepared FA-loaded
shellac fibers by modified coaxial electrospinning and
probed these for colon-targeted drug delivery. In vitro
dissolution tests demonstrated that only a small amount
of FA was released at pH 2, while the sustained release
was obtained at neutral pH. The fact that electrospun
materials generally comprise amorphous solid
dispersions should also permit solubility to be increased.
An alternative approach to enhance solubility is to use
cyclodextrins (CDs), a family of cyclic oligosaccharides
with hydrophilic exteriors, and relatively hydrophobic
cavities. CDs can interact with hydrophobic molecules
to form inclusion complexes via the formation of noncovalent bonds. The complexation of a drug with a CD
also offers benefits in terms of stability, bioavailability,
and absorption enhancement (Wang et al., 2016).
The most common CD used in drug formulation is
hydroxypropyl-β-cyclodextrin (HPβCD), a derivative of
βCD containing seven glucopyranose units. Wang et al.
(2016) have previously proved that 5FU encapsulated in
β-CD derivatives showed improvements in dissolution
properties over the pure drug. Another study investigated
FA incorporated into β- and γ-CD inclusion complexes
and showed that the water solubility of FA was
significantly improved by dint of complex formation
(Casolaro et al., 2005; Wang et al., 2011).
The approach of preparing electrospun nanofibers with
drug-cyclodextrin inclusion complexes has been reported
previously, and found to be potent in enhancing the drug
release from fibers loaded with sulfisoxazole (Aytac et
al., 2015) and ciprofloxacin (Aytac et al., 2019). Coreshell nanofibers with the core composed of a curcuminCD inclusion complex and the shell a blank polymer
have also been successfully fabricated (Aytac & Uyar,
2017). A recent review discusses the electrospinning of
CDs in detail (Topuz & Uyar, 2019).
In this work, 5FU and FA were first encapsulated into
CD complexes to enhance their solubility and dissolution
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rate (Casolaro et al., 2005; Wang et al., 2016). The drugCD composites were then processed, together with a
gadolinium-based magnetic resonance imaging (MRI)
agent, into the core of coaxial electrospun fibers. The
shell comprised a pH-sensitive polymer. These systems
were fabricated with the ultimate aim of developing a
theranostic system.
MATERIALS AND METHODS
Materials
The following were procured for this work: 5-fluorouracil
(5FU, 99%, Acros Organics), ferulic acid (FA, 98%,
Chem Cruz), hydroxypropyl-beta-cyclodextrin (HPβCD,
Sigma Aldrich), hydroxypropyl-gamma-cyclodextrin
(HPγCD, Sigma Aldrich), polyethylene oxide (PEO,
Mw 600,000, Acros Organics and Mw 100,000, Sigma
Aldrich), diethylenetriaminepentaacetic acid gadolinium
(III) hydrate (GdDTPA, 97%, Sigma Aldrich), Eudragit
S100 (MW 125,000, Röhm GmbH), ethanol (99.8%,
Fisher Scientific Ltd), N,N-dimethyl acetamide (DMAc,
99.8%, Sigma Aldrich), hydrochloric acid (HCl, 37%,
Sigma Aldrich), and phosphate-buffered saline tablets
(PBS, VWR). These were used as received without
any further purification. All other chemicals used were
analytical grade.
Preparation of Electrospinning Solutions
In all cases, the fiber shell solution comprised 15% w/v
Eudragit S100 (ES-100) in ethanol: DMAc (9:1 v/v). To
prepare the core solution, drug-cyclodextrin complexes
were first generated by dissolving HPβCD or HPγCD
in water, then adding the drug at a 1:1 molar ratio. The
solution was stirred for 12 h to ensure complex formation
between the drug and cyclodextrin. A solution of PEO in
ethanol was prepared, and then added to the inclusion
complex solution or a solution of the pure drug to give
a final polymer concentration of 1% or 3% w/v, and
stirring continued for 2 h The drug concentration in the
final solution was 10% w/w with respect to PEO, and the
solvent comprised 3:7 v/v water:ethanol. Finally, 10%
GdDTPA (w/w, with respect to PEO) was added to the
solution.
Formation
of
Drug-Cyclodextrin
Inclusion
Complexes
To confirm their formation, the inclusion complexes
were isolated in powder form. HPβCD or HPγCD was
dissolved in water, and then the drug (5FU or FA) added
to the solution at a molar ratio of 1:1. The solution was
stirred for 12 h to ensure complex formation between the
drug and the cyclodextrin. The solid inclusion complex
was recovered by rotary evaporation at 45 °C (Butchi
R-300 instrument).
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Table 1. Details of the formulations prepared
CD

F1a
F1b
F2a
F2b
F3a
F3b
F4a
F4b

HPβCD
HPγCD
HPγCD
HPγCD
-

5FU
5FU
FA
FA
FA
FA
FA
FA

Electrospinning
Coaxial electrospinning was performed to produce the
fibers. The setup consisted of a high voltage power supply
(FuG Elektronik HCP35-35000) and two syringe pumps
(KDS100, Cole-Parmer), which were connected to 5 mL
syringes. The latter was used to eject the core and shell
solutions at constant rates through a coaxial spinneret
(20- and 17-gauge needles were used to dispense the core
and shell fluids, respectively). The fibers formed were
collected on a grounded flat plate, which was wrapped in
aluminum foil and placed at a distance of 25 cm from the
tip of the needle. The voltage was set to 15 kV, the core
solution flow rate at 0.3 mL/h, and the shell solution flow
rate at 1.5 mL/h. All experiments were conducted at 25 ±
3 ºC and 32 – 45 % relative humidity. After production,
the fibers were wrapped in aluminum foil and placed in
a vacuum desiccator for at least 24 h to ensure complete
evaporation of the solvents. A series of formulations
were developed, as detailed in Table 1.
Characterization
The morphology of the fibers was investigated by
scanning electron microscopy (SEM, FEI Quanta 200
FEG ESEM) and transmission electron microscopy
(TEM, Philips/FEI CM120 Bio Twin microscope). The
diameter of the fibers was calculated from the SEM
images by using the ImageJ Software (National Institutes
of Health) to measure the fibers at more than 100 points
in the images, and the results were given as mean ±
S.D. For TEM analysis, samples were collected directly
on TEM grids during the electrospinning process. A
fluorescence microscope (EVOS® FL Cell Imaging
System, ThermoFisher Scientific) with a GFP filter and
a digital camera attached was also used to analyze the
samples.
X-ray diffraction (XRD) patterns were recorded using a
Miniflex 600 diffractometer (Rigaku) supplied with Cu
Kα radiation. Patterns were obtained over the 2θ range
5 – 30° at a speed of 5° per minute (size step 0.02°).
E-ISSN 2477-0612

Core
Polymer solution

Formulation Drug

3%
3%
3%
3%
1%
1%
1%
1%

w/v PEO 0.6M
w/v PEO 0.6M
w/v PEO 0.6M
w/v PEO 0.6M
w/v PEO 0.6M
w/v PEO 0.6M
w/v PEO 0.1M
w/v PEO 0.1M

The generator voltage was 40 kV and current 15 mA.
IR spectra were obtained on a Perkin-Elmer Spectrum
100 instrument, with scans recorded over the range 550
– 4000 cm-1 and the resolution set at 4 cm-1. Differential
scanning calorimetry (DSC) was performed with a TA
Instruments Q2000 calorimeter. Experiments were
carried out with a temperature ramp of 10 °C/min under a
50 mL/min flow of nitrogen, from 25 to 200°C or 300°C.
The CD-drug inclusion complexes were characterized
by SEM, XRD, and IR spectroscopy using the same
methods as detailed above.
In Vitro Drug Release
An in vitro drug release study was performed by first
putting approximately 50 mg of fibers in 50 mL of 0.1 N
aqueous HCl for 2 h, and then transferring them to 50 mL
of phosphate-buffered saline (PBS; pH 7.0) for a further
22 h. The experiments were performed at 37 °C, and the
stirring speed was set at 50 rpm. At pre-determined time
intervals, 3 mL aliquots were withdrawn and replaced
with fresh medium. The drug concentration in the
medium was quantified using a UV spectrophotometer
(Agilent Technologies Cary UV 100) at 322 nm (FA)
or 266 nm (5FU). All experiments were performed in
triplicate.
RESULTS AND DISCUSSION
Formation
Complexes

of

Drug-Cyclodextrin

Inclusion

FTIR spectroscopy
The FTIR spectra of 5FU- HPβCD (Figure 1a) and
FA-HPγCD (Figure 1b) revealed that both HPβCD and
HPγCD displayed similar features: a broad peak at 3028
– 3650 cm-1 corresponds to O-H stretching, the band at
2928 – 2920 cm-1 to C-H stretching vibrations, and peaks
between 1425 – 1456 cm-1 to C-H and C-O vibrations.
An additional absorbance at 1020 cm-1 arised due to the
C-O-C linkage (Wang et al., 2011). In the 5FU spectrum
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(a)
(b)
Figure 1. FTIR Spectra of 5FU, HPβCD, 5FU-HPβCD mixture and 5FU-HPβCD inclusion complex (a); and
FTIR spectra of FA, HPγCD, FA-HPγCD mixture and FA-HPγCD inclusion complex (b)
(Figure 1a), peaks at 2828 - 3125 cm-1 represent C-H
and N-H stretching, bands at 1711 and 1655 cm-1 were
assigned to C=O stretching, while a C-N stretch could
be seen at 1244 cm-1 and a C-F stretch at 998 cm-1
(Illangakoon et al., 2015). The peaks in the range 1429
– 1244 cm-1 corresponded to the substituted pyrimidine
group (Di Donato et al., 2016). The formation of drugcyclodextrin complexes is typically manifested through
the shifting and/or weakening of distinctive bands from
the active ingredient and cyclodextrin (Aytac et al. 2018,
Zidane et al., 2016). The spectrum of a physical mixture
of 5FU and HPβCD (Figure 1a) showed as expected,
a simple juxtaposition of the features of the two raw
materials. The IR spectrum of the 5FU-HPβCD inclusion
complex mainly revealed the peaks of pure HPβCD, with
some shifting of the 5FU peaks also observed. Many of
the characteristic peaks of 5FU (N-H, C-N, C-F, and
substituted pyrimidine peaks at 3125 – 2828 cm-1, 998
cm-1 and 1429 – 1244 cm-1, respectively) cannot be seen
due to the overlapping with the CD bands (Di Donato et
al., 2016; Illangakoon et al., 2015). However, the peaks at
1711 and 1655 cm-1 from 5FU were still present in the IR
pattern of the complex but shifted to 1722 and 1688 cm1,
respectively (cf. the spectrum of a physical mixture),
indicating interactions between the C=O group of 5FU
and HPβCD. The 5FU-HPβCD spectrum obtained is an
agreement with results from previous work (Wang et al.,
2016).
In the FTIR spectrum of FA (Figure 1b), the aromatic
group gave peaks at 1619, 1592, 1510, and 1431 cm-1.
The hydroxyl groups from the alcohol and carboxylic
acid groups stretched in the range 2500 – 3437 cm-1
with a prominent peak at 3431 cm-1, and vibrations at
1267 cm-1 were due to the ether linkage (C-O-C stretch).
There were C=O stretches at 1689 cm-1 and C=C
stretches at 1659 cm-1 (Vashisth et al., 2015; Wang et
al., 2011; Yang et al., 2013). Unlike the spectrum of a
FA-HPγCD physical mixture, which showed strong

signals from the FA phenyl ring, the IR spectrum of FAHPγCD complex mostly resembles that of HPγCD. The
bands distinctive for the aromatic ring of FA (at 1619
–1431 cm-1) as well as the two bands at 851 cm-1 and 802
cm-1 from phenyl C-H groups on FA were shifted and
diminished. This arises due to the complexation of FA
into the HPγCD cavity and overlap with the peaks from
HPγCD. However, a characteristic signal at 1689 cm-1
belonging to the carbonyl group of FA is still observed.
These observations show that the FA-HPγCD inclusion
complex was successfully formed. This result is also in
agreement with studies conducted by Wang et al. (2011)
and Casolaro et al. (2005).

Figure 2. XRD patterns of the drugs, cyclodextrins,
drug-cyclodexterin mixtures and drug-cyclodextrin
inclusion complexes
XRD patterns
XRD patterns were presented in Figure 2. HPβCD and
HPγCD showed broad haloes in their pattern, as is
typical for amorphous materials. Bragg reflections from
5FU were observed at 2θ = 16°, 18°, 20°, 22°, 24°, 28°,
32°, and 34° (Wang et al., 2016). FA shows reflections
at 2θ = 8°, 13°, 16°, 18°, 22°, 26°, 29° and 32° (Wang
et al., 2011). These sharp Bragg reflections arise due to
E-ISSN 2477-0612
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(b)

(c)

(d)

Figure 3. SEM micrographs of 5FU (a), HPβCD (b), physical mixtures of 5FU-HPβCD (c), 5FU-HPβCD
inclusion complexes (d).

(a)
(b)
(c)
(d)
Figure 4. SEM micrographs of FA (a), HPγCD (b), physical mixtures of FA-HPγCD (c), FA-HPγCD inclusion
complexes (d)
the pure drug species comprising crystalline materials.
Physical mixtures of the drug and cyclodextrin still
contained distinctive reflections from pure drugs. In
contrast, the 5FU-HPβCD and FA-HPγCD inclusion
complexes have XRD patterns comprising broad
haloes; the characteristic reflections of both 5FU and
FA are absent, which confirms successful complexation
(Anselmi et al., 2006).
Morphology
The surface morphology of the raw materials, physical
mixtures, and inclusion complexes were assessed by
SEM. Figure 3 showed that 5FU exists as large (ca. 100
– 200 µm) particles with irregular shapes, while HPβCD
comprised amorphous-looking approximately spherical
particles. A physical mixture of 5FU and HPβCD
did not show any significant changes in morphology,
and 5FU particles could be seen to be mixed with the
HPβCD particles. In contrast, the 5FU-HPβCD inclusion
complexes took the form of large (> 200 µm) particles
with a very different morphology to the precursors.
These SEM results were in agreement with previous
research by Wang et al. (2016). The same trends were
seen for FA (Figure 4). Pure FA comprised needle-like
crystals, while HPγCD took the form of amorphouslooking spherical particles. In the physical mixture of
FA and HPγCD, FA crystals were clearly observed to be
mixed with HPγCD, without any changes in morphology.
The inclusion complexes consisted of irregular shaped
E-ISSN 2477-0612

Figure 5. DSC data of the drugs, cyclodextrins and
drug-cyclodextrin inclusion complexes
particles having very different morphology to FA
and HPγCD, with sizes around 100 – 300 µm. These
observations again confirmed the formation of the drugcyclodextrin inclusion complex.
DSC data
DSC data of the drugs and complexes were given in
Figure 5. 5FU shows a melt at 283.5 °C, in accordance
with the results of Illangakoon et al. (2015). This verified
that the drug exists in the crystalline form, as indicated
by XRD. FA shows a sharp endothermic peak at 173.2
°C, similar to results obtained by Anselmi et al., (2006).
This peak corresponded to the FA melting point, again
consistent with the XRD data. Both HPβCD and HPγCD
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Table 2. The diameters of the formulated fibers
Core

Formulation

Drug

CD

Polymer

Diameter (µm)

F1a
F1b
F2a
F2b

5FU
5FU
FA
FA

HPβCD
HPγCD

3 % w/v PEO 0.6M
3 % w/v PEO 0.6M
3 % w/v PEO 0.6M
3 % w/v PEO 0.6M

3.65 ± 1.20
4.24 ± 1.23
3.74 ± 1.13
5.08 ± 1.28

F3a
F3b
F4a
F4b

FA
FA
FA
FA

HPγCD
HPγCD

1 % w/v PEO 0.6M
1 % w/v PEO 0.6M
1 % w/v PEO 0.1M
1 % w/v PEO 0.1M

1.41 ± 0.59
2.42 ± 0.57
2.96 ± 0.78
4.57 ± 1.00

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

Figure 6. SEM images of the fibers F1a (a), F1b (b), F2a (c), F2b (d), F3a (e), F3b (f), F4a (g), and F4b (h)
prepared in this work
showed broad endotherms in the temperature range
75-125°C corresponding to the loss of sorbed water,
which was in agreement with previous work (Wang et
al., 2016). The DSC traces of the inclusion complexes
did not show any melting endotherms from 5FU or FA,
indicating that the drugs were successfully incorporated
in the cyclodextrin derivatives to generate amorphous
formulations, as was also evidenced by XRD.
Electrospun Fibers
Fiber morphology
SEM images of the fibers were displayed in Figure 6.
The fibers were smooth and bead-free with no drug
crystals visible, indicating that 5FU and FA had been
successfully encapsulated in the fibers. All the fibers

were flat and ribbon-like, with diameters in the range of
1.41 to 5.08 µm (Table 2). The flat shape was expected
to arise because when the polymer solution was ejected,
the shell solvent on the outer part of the jet solution
was rapidly evaporated, and a thin polymer skin with a
liquid core was formed. This was to be expected given
that the core contains water, which is much less volatile
than the ethanol used to prepare the shell solution. After
the polymer jet reached the collector, the solvent inside
subsequently evaporated, and the cylindrical shape of
the fiber thus collapsed, resulting in a ribbon-like shape
(Baji et al., 2010; Huang et al., 2006).
Overall, the diameters of fibers containing the
cyclodextrin inclusion complex were larger than the
free-drug formulations (Table 2). This result was
E-ISSN 2477-0612
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(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

Figure 7. TEM images of fibers F1a (a), F1b (b), F2a (c), F2b (d), F3a (e), F3b (f), F4a (g), and
F4b (h) prepared.

(a)

(b)

Figure 8. FTIR spectra of the raw materials (a), and the fibers (b).
consistent with a previous study by Samprasit et al.,
(2015). These authors ascribed the larger diameter of
the drug-cyclodextrin inclusion complex systems to be
a result of the higher viscosity of the solution with the
CD present, which led to a greater amount of polymer
chain entanglement in the solution and thus bigger
fibers (Huang et al., 2006; Samprasit et al., 2015).
Larger diameter fibers were also observed with a higher
molecular weight of PEO in the core.
In order to observe the internal structure of the fibers,
TEM analysis was conducted. As shown in Figure 7, all
of the formulations had clear core-shell structures.
FTIR spectra
IR spectra of the raw materials were given in Figure 8a.
The characteristic peaks at 1571 cm-1 and 1405 cm-1 in
the Gd(DTPA) spectrum were due to asymmetric and
E-ISSN 2477-0612

symmetric COO stretching vibrations (Huang et al.,
2006). In the spectrum of PEO, the peak at 2882 cm-1
was due to C-H stretching, and that at 1095 cm-1 was
assigned to C-O-C stretching (Krstic et al., 2017). ES-100
exhibited characteristic vibrations from C-H stretching
at 2997 cm-1 and 2952 cm-1, C=O stretching at 1724 cm1,
and C-O-C stretching (ester linkage) at 1257 cm-1 and
1148 cm-1 (Illangakoon et al., 2015). Figure 8b showed
the spectra of the fibers. The major peaks were visible
at 1724, 1257, and 1148 cm-1 corresponded to ES-100.
A band at ca. 1000 cm-1 attributed to the C-O-C linkage
of PEO was also observed. Further, an intensified peak
at 1608-1612 cm-1 could be seen in the fibers’ spectra,
which was due to the C=O groups of 5FU (F1a, F1b)
or FA (F2a-F4d). This showed that the drugs and drugcyclodextrin complexes were successfully incorporated
into the fiber system. These findings were in agreement
with the literature (Jin et al., 2016).
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semi-crystalline form (Jin et al., 2016; Krstic et al.,
2017). However, the endothermic peak of PEO could
not be seen in the fiber traces, indicating the format
of the core-shell system. This was consistent with the
previous study for PEO/ES100 core-shell system by
Jin et al. (2016). All of the fiber formulations showed a
broad endothermic peak over the temperature range from
around 50 to 140°C, which was attributed to the loss of
water. No melting endotherms from the drug contents
were seen, confirming the fibers to exist as amorphous
solid dispersions.
Figure 9. XRD patterns of the fibers and raw materials
XRD
XRD patterns (Figure 9) demonstrated that ES-100
was an amorphous material, with no distinct Bragg
reflections in its pattern. PEO exhibited two peaks at
19° and 23°, as a result of its semi-crystalline structure
(Azli et al., 2015; Pandey et al., 2009). All the fibers
had characteristic XRD patterns of amorphous systems,
with only broad haloes visible. The drug molecules
or complexes were thus distributed in the fibers in an
amorphous state. This agreed with the results of previous
studies: it is well known that the electrospinning process
typically prevents crystallization because of the very
rapid solvent evaporation process (Aytac et al., 2015;
Aytac et al., 2016).
DSC
From the DSC data (Figure 10a-b), it could be seen
that Eudragit S100 had a broad endothermic peak over
the temperature range 55 to 125°C, consistent with
the literature (Illangakoon et al., 2015) and showing
the loss of absorbed and adsorbed water (Mithu et
al., 2017). PEO exhibited a sharp endothermic peak
at 68°C, corresponding to its melting transition from

(a)

Drug Release Study
Drug release data were given in Figure 11. Eudragit
S100, which comprised the shell, was only soluble above
pH 7.0 and therefore was expected to be able to prevent
the release of the drug in the initial low pH environment
(Mithu et al., 2017). Unexpectedly however, all the
formulations released their drug cargo rapidly in low
pH conditions. More than 80 % of the drug loading was
released in 30 min, and within 1 h essentially 100 % release
was reached. The release study of F3a and F4a were not
conducted as F1a and F2a showed similar burst release
result. The release of 5FU can be explained by a similar
rationale to that proposed by Illangakoon et al. (2015):
5FU is a low molecular weight drug and has a relatively
high solubility at low pH, which gives it a propensity to
detach from the cyclodextrin cage, penetrate through the
fibers and dissolve into solution. However, the release
of FA at pH 1 was more confusing. To investigate this,
SEM images of the fibers after 2 h immersion in HCl
were obtained. The SEM images of F1b and F2b given
in Figure 12 clearly showed the morphology of the fibers
had changed after 2 h immersion in 0.1 N HCl. The
smooth ribbon-like fibers had swollen and formed pores.
This might arised due to the permeation of water into
the fibers and PEO in the core swelling, which in turn
caused the shell to rupture and yield pores that allow the

(b)

Figure 10. DSC data of the raw materials (a) and the fibers (b).

E-ISSN 2477-0612

42

Pharm Sci Res, Vol 7 No 1, 2020

Fatimah, et al.

(a)
(b)
Figure 13. SEM images of F3b (a) and F4b (b) after 2
hours immersion in HCl (a).
Figure 11. In vitro drug release from the fibers

(a)
(b)
Figure 12. SEM images of F1b (a) and F2b (b) after 2
hours immersion in HCl.
drugs to diffuse out of the polymer matrix. In addition,
when we compared the drug-loaded (F1a) and drug-CD
loaded (F1b) nanofibers, the solubility increment that
was expected to be provided by cyclodextrin-inclusion
complex formation was not observed.
The same release patterns of drug release were seen
regardless of the drug loading and PEO molecular weight:
F3b and F4b, which used a lower concentration of PEO
than F2a and F2b (Table 1) did not give significantly
different results to those of F1a,b, and F2a,b. SEM images
of F3b and F4b after immersion in HCl showed smooth
fibers without pores, however (Figure 13). Although
the TEM results showed clear images of separate core
and shell compartments, some mixing of the core and
shell fluids might occur during electrospinning, since
the solutions were prepared in miscible solvent systems.
A similar hypothesis could also be drawn for F1a,b and
F2a,b, but in these cases, it was clear that there were very
marked changes in fiber morphology, which were likely
to be at least partially responsible for the release pattern
noted.
Therefore, we postulated that at least in the case of the
F3a,b, and F4a, b fibers, some of the drug content might
be present on the surface of the fibers. To probe this,
we exploited the fact that FA was known to show bluegreen fluorescence (Inokuchi et al., 2016). Fluorescence
microscopy images of the fibers (Figure 14) were
recorded, and it was observed that intense fluorescence
was visible at the exterior of the fibers. The intensity from
E-ISSN 2477-0612

(a)
(b)
Figure 14. Fluorescence images of F3b (a) and F4b
(b) fibers.
the fiber exterior was notably brighter than that from the
interior, indicating that at least some of the drugs had
migrated from the core to the shell.
This work, in conjunction with the previously reported
findings of Illangakoon et al. (2015) indicated that great
care must be taken when preparing core/shell fibers for
pH-triggered drug release. It is clear that a number of
factors can cause the drug to be released from the fibers
at low pH, even if the drug is loaded only in the core
solution, inclusion complexes are formed, and the shell
is insoluble in acidic conditions. Cautious selection of
the operating parameters and the solutions to be used in
electrospinning is required to yield the required results.
CONCLUSION
A series of new formulations in the form of core-shell
electrospun fibers was reported in this work. These
contained anticancer drugs (5-fluorouracil or ferulic
acid) or their cyclodextrin inclusion complexes, together
with a gadolinium-based magnetic resonance imaging
contrast agent, in the core. Their shell comprised
Eudragit S100. SEM images showed the formation of
smooth ribbon-like fibers, with diameters ranging from
1.41 to 5.08 µm, and a clear interface between core and
shell compartments was observed by TEM. IR, XRD
and DSC data confirmed the encapsulation of the drug
into the cyclodextrin cavity and the formation of fibers
comprising amorphous solid dispersions. Drug release
from the systems at pH 1 and 7 was also investigated.
These showed that all the drug was released within one
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hour at pH 1. This is attributed to the movement of drug
from the core to the shell compartment of the fibers, and/
or the permeation of water into the core compartment
causing this to swell and the fibers to burst.
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